Cargando…

Correlation Analysis of the Therapy Adherence to Long-Acting Inhalers Among Patients with Stable COPD

PURPOSE: Long-acting inhalers are the mainstay maintenance therapy for stable chronic obstructive pulmonary disease (COPD) management. The aim of this study was to assess adherence to inhalers among adults with COPD in China and to develop strategies to improve adherence for the next step. PATIENTS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Xin, Liu, Shanling, Huang, Li, Wu, Ying, Wen, Long, Liu, Jiheng, Tang, Yuling, Liu, Xiaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284155/ https://www.ncbi.nlm.nih.gov/pubmed/37350779 http://dx.doi.org/10.2147/PPA.S413948

Ejemplares similares

Improving adherence with inhaler therapy in COPD
por: Lareau, Suzanne C, et al.
Publicado: (2010)

Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis
por: Peng, Yating, et al.
Publicado: (2021)

COPD: understanding patients’ adherence to inhaled medications
por: Duarte-de-Araújo, António, et al.
Publicado: (2018)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
por: Jardim, Jose R., et al.
Publicado: (2019)

Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
por: Kang, Jieun, et al.
Publicado: (2017)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
por: Asche, Carl Victor, et al.
Publicado: (2012)

Relevance of dosage in adherence to treatment with long-acting anticholinergics in patients with COPD
por: Izquierdo, José Luis, et al.
Publicado: (2016)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Inhalation Therapy for Stable COPD: 20 Years of GOLD Reports
por: Terry, Paul D., et al.
Publicado: (2020)

Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials
por: Li, Chenxi, et al.
Publicado: (2019)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD
por: Jara, Michele, et al.
Publicado: (2012)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
por: Bishwakarma, Raju, et al.
Publicado: (2017)

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
por: Halpin, David M. G., et al.
Publicado: (2016)

Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients
por: Plaza, Vicente, et al.
Publicado: (2016)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2016)

The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients
por: Darbà, Josep, et al.
Publicado: (2015)

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
por: Kozma, Chris M, et al.
Publicado: (2011)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
por: Lee, Suh-Young, et al.
Publicado: (2016)

Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
por: Turégano-Yedro, Miguel, et al.
Publicado: (2023)

Association of blood eosinophils and plasma periostin with FEV(1) response after 3-month inhaled corticosteroid and long-acting beta(2)-agonist treatment in stable COPD patients
por: Park, Hye Yun, et al.
Publicado: (2015)

Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China
por: Lin, Ling, et al.
Publicado: (2023)

Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
por: Caminati, Marco, et al.
Publicado: (2020)

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
por: Averell, Carlyne M., et al.
Publicado: (2022)

Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
por: Humenberger, Magdalena, et al.
Publicado: (2018)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
por: Terry, Paul D., et al.
Publicado: (2023)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
por: Yang, Hsi-Hsing, et al.
Publicado: (2017)

Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β(2)-agonist via dry-powder inhalers and pressurized metered-dose inhalers
por: Wittbrodt, Eric T, et al.
Publicado: (2018)

Application of Once-Monthly Self-Reported ACT Questionnaire in Management of Adherence to Inhalers in Outpatients with Asthma
por: Zhang, Jing, et al.
Publicado: (2020)

Inhaler Technique and Self-reported Adherence to Medications Among Hospitalised People with Asthma and COPD
por: Elander, Astrid, et al.
Publicado: (2020)

Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
por: Ridolo, Erminia, et al.
Publicado: (2013)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
por: Scichilone, Nicola, et al.
Publicado: (2014)

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis
por: Xia, Ning, et al.
Publicado: (2015)

Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
por: Huang, Tsan-Ming, et al.
Publicado: (2020)

Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma
por: Xu, Jianhua, et al.
Publicado: (2022)

Correlation between serum IL-32 concentration and clinical parameters of stable COPD: a retrospective clinical analysis
por: Rong, Biaoxue, et al.
Publicado: (2020)

Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study
por: Montes de Oca, Maria, et al.
Publicado: (2017)

Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cj2dk8fkev4h805v8mpmnkp3np